Ocular affects of hydroxychloroquine treatment in rheumatoid arthritis patients

ABSTRACT

Hydroxychloroquine is an antimalarial drug which is used as a part of combination DMARD therapy in patients with Rheumatoid arthritis. Eye toxicity because of the accumulation of the drug in the Retina is the most serious adverse effect. The purpose of this study is to detect ocular affects of hydroxychloroquine treatment in low risk patients [without renal or liver disease] for longer duration